Cashu | Summary

DJI

-0.41%

SPX

-0.10%

IXIC

-0.09%

FTSE

+0.37%

N225

+1.85%

AXJO

+0.43%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

-0.41%

SPX

-0.10%

IXIC

-0.09%

FTSE

+0.37%

N225

+1.85%

AXJO

+0.43%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

393.76M

Dividend Yield

0.00%

P/E Ratio

-2.24

EPS

-4.60

Revenue

83.33M

Avg. Volume

636.71K

About

What does RGNX do?

REGENXBIO, a clinical-stage biotechnology company based in Rockville, Maryland, specializes in gene therapy using its NAV Technology Platform for retinal, neuromuscular, and neurodegenerative diseases. Its key therapies include ABBV-RGX-314, RGX-202, and RGX-121.

Sector

💻 Health Care

IPO

CEO

Employees

353

Headquarters

Maryland, USA

Website

http://www.regenxbio.com